新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2RBD Potent NeutralizingAntibody, Chimeric mAb, Human IgG1 (AM128)-蛋白质/抗原/多肽-试剂-生物在线
北京百普赛斯生物科技股份有限公司
新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2RBD Potent NeutralizingAntibody, Chimeric mAb, Human IgG1 (AM128)

新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2RBD Potent NeutralizingAntibody, Chimeric mAb, Human IgG1 (AM128)

商家询价

产品名称: 新冠病毒spike蛋白中和抗体Anti-SARS-CoV-2RBD Potent NeutralizingAntibody, Chimeric mAb, Human IgG1 (AM128)

英文名称: Anti-SARS-CoV-2RBD Potent NeutralizingAntibody, Chimeric mAb, Human IgG1 (AM128)

产品编号: SPD-M128

产品价格: 0

产品产地: USA

品牌商标: ACROBiosystems

更新时间: null

使用范围: null

北京百普赛斯生物科技股份有限公司
  • 联系人 :
  • 地址 : 北京经济技术开发区宏达北路8号5号楼4层
  • 邮编 : 100176
  • 所在区域 : 北京
  • 电话 : 点击查看
  • 传真 : 点击查看
  • 邮箱 : order.cn@acrobiosystems.com

Anti-SARS-CoV-2RBD Potent NeutralizingAntibody, Chimeric mAb, Human IgG1 (AM128) (SPD-M128) is a chimeric monoclonal antibody combining the constant domains of the human IgG1 molecule with mouse variable regions. Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARS-CoV-2 Spike protein.

Isotype

Human IgG1/kappa

Specificity

This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain. No cross-reactivity is detected with Spike protein RBD domain of other coronaviruses, including SARS-CoV, MERS-CoV, HCoV-229E,HCoV-NL63,HCoV-OC43 and HCoV-HKU1.

Purity

>95% as determined by SDS-PAGE.

Bioactivity